Dow Down3.39% Nasdaq Down4.12%

Recro Pharma, Inc. (REPH)

-NasdaqCM
7.90 Down 0.04(0.50%) 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Avg. Estimate-0.78-0.98-3.41-2.85
No. of Analysts2.002.002.002.00
Low Estimate-0.95-1.04-3.87-3.69
High Estimate-0.61-0.91-2.94-2.00
Year Ago EPS-0.17-0.240.21-3.41
Revenue EstCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Avg. Estimate13.00M15.08M13.00M58.90M
No. of Analysts1211
Low Estimate13.00M13.00M13.00M58.90M
High Estimate13.00M17.15M13.00M58.90M
Year Ago Sales18.66M16.54M51.95M13.00M
Sales Growth (year/est)-30.30%-8.80%-75.00%353.10%
Earnings HistoryJun 15Sep 15Dec 15Mar 16
EPS Est-0.03-0.20-0.43-0.66
EPS Actual-0.17-0.241.13-0.71
Difference-0.14-0.041.56-0.05
Surprise %-466.70%-20.00%362.80%-7.60%
EPS TrendsCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Current Estimate-0.78-0.98-3.41-2.85
7 Days Ago-0.78-0.98-3.41-2.85
30 Days Ago-0.78-0.98-3.41-2.85
60 Days Ago-0.83-1.00-3.68-3.58
90 Days Ago-0.54-0.64-2.42-2.27
EPS RevisionsCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstREPHIndustrySectorS&P 500
Current Qtr.-358.80%N/A-55.10%6.80%
Next Qtr.-308.30%N/AN/A15.30%
This Year-1,723.80%N/A6.70%0.60%
Next Year16.40%N/A45.70%12.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A25.76%17.92%7.42%
Price/Earnings (avg. for comparison categories)-2.3324.779.8618.27
PEG Ratio (avg. for comparison categories)N/A2.201.491.15
Currency in USD.